Disturbed frontal regulation of attention in Parkinson's disease

C J Stam, S L Visser, A A Op de Coul, L M De Sonneville, R L Schellens, C H Brunia, J S de Smet, G Gielen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Parkinson's disease is characterized not only by tremor, akinesia and rigidity, but also by frontal cognitive dysfunction, that can be understood as a disturbance in the 'Supervisory Attentional System' (SAS). This concept refers to a system, located in the frontal cortex, that regulates attentional processes under novel, non-routine conditions. The hypothesis that cognitive dysfunction in Parkinson's disease results from a disturbance in the SAS was investigated by recording 'processing negativity' in 33 parkinsonian patients and 17 controls. Processing negativity is an event-related potential that reflects neuronal activity during selective attention. The contribution of the frontal cortex to selective attention can be studied directly using processing negativity. Parkinsonian patients were also scored for clinical symptoms and subjected to a neuropsychological test battery. Processing negativity was clearly disturbed in the parkinsonian patients. Moreover, parkinsonian patients with the lowest scores on 'frontal' neuropsychological tests such as Stroop, Trail Making and Word Fluency, also had the lowest processing negativity. Our results support the hypothesis that cognitive dysfunction in Parkinson's disease might be understood as a disturbance in the frontal regulation of attentional processes. Degeneration of the dopaminergic mesocortical innervation of the frontal cortex in Parkinson's disease is a possible neurochemical substrate of these frontal attentional disturbances.

Original languageEnglish
Pages (from-to)1139-58
Number of pages20
JournalBrain
Volume116 ( Pt 5)
Publication statusPublished - Oct 1993

Cite this

Stam, C. J., Visser, S. L., Op de Coul, A. A., De Sonneville, L. M., Schellens, R. L., Brunia, C. H., ... Gielen, G. (1993). Disturbed frontal regulation of attention in Parkinson's disease. Brain, 116 ( Pt 5), 1139-58.